A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Clinical trial NCT03324503 · COMPLETED

Trial details

NCT number: NCT03324503
Sponsor: Celgene
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sarcoidosis, Pulmonary

Start date: 2017-12-08
Primary completion: 2019-11-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.